With Chai-2, we’re moving de novo antibody design past binding and closer than ever to real therapeutics.
With Chai-2, we’re moving de novo antibody design past binding and closer than ever to real therapeutics.
Drug-like antibody design against challenging targets with atomic precision
Chai Discovery Team
Blog
Read More
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development
TechCrunch
News
Read More
With new AI deal, Eli Lilly and Chai Discovery kick off a 'year of deployment' in pharma
Endpoints
News
Read More
Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate Biologics Discovery
Business Wire
News
Read More
Chai Discovery becomes newest AI unicorn, raising $130M Series B at $1.3B valuation
Endpoints
News
Read More
Chai Discovery Announces $130 Million Series B To Transform Molecular Discovery
Business Wire
News
Read More
OpenAI-Backed Chai Discovery Raises $130 Million for AI-Designed Molecules
Bloomberg
News
Read More
Series B
Chai Discovery Team
Blog
Read More
The Endpoints 11: OpenAI-backed Chai Discovery’s brainiac quartet aims to design drugs on the computer
Endpoints
News
Read More
OpenAI-backed Chai raises $70mn for AI-driven drug discovery
Financial Times
News
Read More
OpenAI-backed biotech Chai Discovery raises $70M Series A
Endpoints
News
Read More
Chai Discovery Announces $70 million Series A To Transform Molecular Design
Business Wire
News
Read More
Series A
Chai Discovery Team
Blog
Read More
OpenAI-backed startup releases new AI models, claiming top performance in making antibodies
Endpoints
News
Read More
Chai Discovery Unveils Chai-2 Breakthrough, Achieving Fully De Novo Antibody Design With AI
Business Wire
News
Read More
Introducing Chai-2: Zero-shot antibody design in a 24-well plate
Chai Discovery Team
Blog
Read More
New OpenBind consortium to make the UK a leader in AI-driven drug discovery
UK Government
News
Read More
Drug discovery platform raises $30M as AI health-tech companies continue to attract investors
Crains
News
Read More
OpenAI-backed start-up unveils Chai-1 AI model for drug discovery
FirstWord Pharma
News
Read More
OpenAI, Thrive Capital Back Six-Month-Old AI Drug Discovery Startup
Bloomberg
News
Read More
Introducing Chai-1: Decoding the molecular interactions of life
Chai Discovery Team
Blog
Read More
Seed
Chai Discovery Team
Blog
Read More
© 2026 All rights reserved.